로딩 중…
StockDiggingStockDigging

이글벳

044960· KOSDAQ
₩3,035-1.94%
2026-06-19

Price Chart

이글벳-31.64%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap38.37B KRW
Revenue43.61B KRW
Net Income4.33B KRW
Total Assets65.33B KRW
Net Assets52.38B KRW
Employees110
Value
P/E8.85x
P/B0.73x
PEG0.24x
P/S0.88x
EV/EBITDA9.59x
Profitability
ROE8.28%
ROA6.63%
Op. Margin10.00%
Revenue Growth2.68%
Earnings Growth36.69%
Financial Health
Debt Ratio124.72%
Total Debt8.49B KRW
Cash5.05B KRW
Current Ratio3.41x
Net Debt/EBITDA0.79x
Dividend
Div. Yield2.59%
Div. Growth33.33%
Performance
1Y Return-31.64%
1M Return-16.62%
From 52W High-37.29%
1Y MDD-35.53%
Trading
Volume32,625 shares
Foreign Own.1.58%
Per Share
EPS343 KRW
BPS4,267 KRW

Company Info

CEO 강승조, 강태성(각자 대표이사)
Employees 110
Founded 1983
HQ 충청남도 예산군, KR

Iglobet, established in 1983, manufactures, imports, and sells animal pharmaceuticals for major livestock species, while also developing new businesses in pet pharmaceuticals, feed, and accessories. The company, which was listed on KOSDAQ in 2000, obtained EU GMP certification for sterile injectable drugs in 2017, establishing a foothold for European exports. It employs a sales strategy that shares profits with distributors through its SD policy. Iglobet is headquartered in Yesan-gun, Chungcheongnam-do.